NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ardent and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On November 12, ...

Core Viewpoint - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc., focusing on whether the company and its executives made false or misleading statements or failed to disclose material information to investors [1][2]. Company Overview - Ardent Health, Inc. is a healthcare provider operating in growing midsize urban communities across the United States [2]. - The company raised $192 million in its initial public offering on July 18, 2024, selling 12 million shares at $16 per share [2]. Recent Developments - On November 12, 2025, Ardent Health announced its third quarter 2025 earnings, which missed consensus estimates primarily due to pronounced payor denials and a $54 million adjustment related to adverse prior period claim developments from 2019 to 2022 [3]. - The CFO, Alfred Lumsdaine, indicated that a "change in accounting estimate" led to the earlier recognition of reserves, resulting in a revenue reduction of $43 million for the quarter [3].

SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and ...

Core Viewpoint - Edelson Lechtzin LLP is investigating Ardent Health, Inc. for potential violations of federal securities laws due to allegations of misleading business information provided to investors [1]. Company Overview - Ardent Health, founded in 2001, operates a network of 30 hospitals and over 280 care locations across six states, catering to mid-sized communities with a diverse range of healthcare services [2]. Alleged Wrongdoing - On November 12, 2025, Ardent Health reported third-quarter results that did not meet expectations, primarily due to an increase in insurance claim denials and a $54 million adjustment related to prior claims and litigation in New Mexico involving a former provider [3]. - The company revised its accounting estimates, leading to an earlier recognition of reserves, which resulted in a $43 million reduction in reported revenue for the quarter [3]. - Following this announcement, Ardent Health's stock price dropped by over 33% on November 13, 2025 [4].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Group 1: Investigation Details - The investigation is being conducted by Bleichmar Fonti & Auld LLP, a leading securities law firm [1]. - Ardent Health operates a network of hospitals, ambulatory facilities, and physician practices in mid-sized urban communities across the U.S. [2]. Group 2: Financial Impact - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting "hindsight evaluations of historical collection trends" [3]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [3]. - Following these announcements, Ardent's stock price dropped over 33% during trading on November 13, 2025 [3].

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLPis investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT), focused on whether Ardent Health and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and would like to ...

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue after conducting evaluations of historical collection trends [3]. - The company increased its professional liability reserves by $54 million due to adverse developments from claims between 2019 and 2022, as well as broader industry trends [3]. Stock Market Reaction - Following the financial report on November 12, 2025, Ardent's stock price dropped over 33% during trading on November 13, 2025 [3].

Core Insights - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc., focusing on whether the company and its executives made false or misleading statements or failed to disclose material information to investors [1] Company Overview - Ardent Health is a healthcare provider operating in growing midsize urban communities across the United States [3] - The company raised $192 million in its initial public offering on July 18, 2024, selling 12 million shares at $16 per share [3] Recent Developments - On November 12, 2025, Ardent Health announced its third quarter 2025 earnings, missing consensus estimates primarily due to pronounced payor denials and a $54 million adjustment related to adverse prior period claim developments from 2019 to 2022 [4] - The CFO, Alfred Lumsdaine, indicated that a "change in accounting estimate" led to the earlier recognition of reserves, resulting in a revenue reduction of $43 million for the quarter [4]

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [2][4]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting "hindsight evaluations of historical collection trends" [5]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [5]. - Following these disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [5]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages investors who lost money to contact them for potential legal options [2][6]. - The firm operates on a contingency fee basis, meaning shareholders are not responsible for court costs or litigation expenses [6].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue after conducting evaluations of historical collection trends [3]. - The company increased its professional liability reserves by $54 million due to adverse developments from claims between 2019 and 2022, as well as broader industry trends [3]. Stock Market Reaction - Following the financial report on November 12, 2025, Ardent's stock price dropped over 33% during trading on November 13, 2025 [3].